The Ottawa AF Cardioversion Protocol
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 389 participants.
Also called NCT02192957
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 389 participants
- Sponsor
- David Birnie
- Registry
-
NCT02192957
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT02192957. Allocation not applicable; no masking; primary purpose treatment. Start 2015-08 (registry gives no type); primary completion 2017-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Ottawa AF Cardioversion Protocol
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Lifepak 20E Defibrillator, Licence No: 61944
- Lead sponsor
- David Birnie
Record details
- Record id
cardio:ct-nct02192957- Content hash
285548a94a5f12a0b3bebdd50d9b154659a4b5537fd1b5808cf98395da815086